Regulatory agencies from Latin America and around the world will give their views on efforts to harmonize global regulation at the DIA’s 5th Latin American Regulatory Conference (LARC) 2013, to be held in Bogota, Colombia from May 15-16.
Representatives will be attending from Colombia (INVIMA), Ecuador and Guatemala (MoH), Chile (ISPCH), Brazil (ANVISA), the USA and Costa Rica (FDA), Canada (Health Canada), Spain (AEMPS), and Peru (DIGEMID). Global organizations including the Pan American Health Organization and the World Health Organization will also be taking part.
The event will focus on “Pharma-Co-Vergence” – the act of achieving pharmaceutical regulatory convergence through stakeholders’ collaboration – highlighting the truly collaborative spirit of this multidisciplinary global conference
Dr. Sergio Guerrero, DIA Advisory Council of Latin America (ACLA) president, said: “Based on the success of previous Latin American Regulatory Conferences, DIA will continue to present this dynamic symposium involving key stake holders to influence the advancement of regulatory convergence initiatives within Latin America. Join global regulators, industry and academia to engage in strategic discussion of the current regulatory landscape, future research and drug development in Latin America.”
Key topics at the event include:
- Regulatory Landscape and Convergence Initiatives
- Strengthening the Regulatory Framework
- Efforts Underway by Convergence Initiatives
- Reviews and Inspections
- Ethics Committee Research in the Regions
- Post-market Research Studies and Better Medicines to Influence
- Efficacy and Effectiveness
- Perspectives and Regulations of Pediatric Studies
- Drug Safety, Marketing Surveillance and Quality Control Monitoring
- Regulatory Concerns: Health Systems and Security of the Supply Chain
- Current Regulations of Biologics and Biosimilars
- Emerging Topics
For more information or to register visit www.diahome.org/LARC2013.
ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.